Primary central nervous system lymphomas express immunohistochemical factors of autophagy

Abstract Primary central nervous system lymphoma (PCNSL) is an aggressive and rare disease. Autophagy is a catabolic mechanism boosting various tumors, including lymphomas; its inhibition is thus a promising therapeutic target. Its presence has never been studied in PCNSLs. We conducted a retrospect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Georgia Karpathiou, Silvia-Maria Babiuc, Florian Camy, Elise Ferrand, Alexandra Papoudou-Bai, Jean Marc Dumollard, Jerome Cornillon, Michel Peoc’h
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/837f0784766340ea88d282e1ac2346c4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:837f0784766340ea88d282e1ac2346c4
record_format dspace
spelling oai:doaj.org-article:837f0784766340ea88d282e1ac2346c42021-11-21T12:24:38ZPrimary central nervous system lymphomas express immunohistochemical factors of autophagy10.1038/s41598-021-01693-62045-2322https://doaj.org/article/837f0784766340ea88d282e1ac2346c42021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01693-6https://doaj.org/toc/2045-2322Abstract Primary central nervous system lymphoma (PCNSL) is an aggressive and rare disease. Autophagy is a catabolic mechanism boosting various tumors, including lymphomas; its inhibition is thus a promising therapeutic target. Its presence has never been studied in PCNSLs. We conducted a retrospective immunohistochemical study of 25 PCNSLs for LC3B, p62, and M6PR, comparing it with clinicopathological characteristics. Fourteen (56%) and eleven (44%) PCNSLs were of low and high LC3B expression, respectively. p62 expression was present in most tumors (n = 21, 84%). M6PR was present in all tumors, with 14 (56%) and 11 (44%) cases being of low and high M6PR expression, respectively. LC3B expression was correlated with the performance status (PS) (p = 0.04). No association was found with other clinical parameters, such as deep structure invasion, multiple lesions, complete response, and recurrence after response. p62 showed a strong positive association with MUM1 expression (p = 0.0005). M6PR expression showed a positive correlation (p = 0.04) with PD-L1 expression. No association was found with p53, Ki67, CD8, BCL2, BCL6, or double MYC/BLC2 co-expressors. No association of LC3B, p62, and M6PR expression with survival was found. Our findings provide evidence for the possible presence of autophagic markers in PCNSLs and, thus, for possible treatment targets.Georgia KarpathiouSilvia-Maria BabiucFlorian CamyElise FerrandAlexandra Papoudou-BaiJean Marc DumollardJerome CornillonMichel Peoc’hNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Georgia Karpathiou
Silvia-Maria Babiuc
Florian Camy
Elise Ferrand
Alexandra Papoudou-Bai
Jean Marc Dumollard
Jerome Cornillon
Michel Peoc’h
Primary central nervous system lymphomas express immunohistochemical factors of autophagy
description Abstract Primary central nervous system lymphoma (PCNSL) is an aggressive and rare disease. Autophagy is a catabolic mechanism boosting various tumors, including lymphomas; its inhibition is thus a promising therapeutic target. Its presence has never been studied in PCNSLs. We conducted a retrospective immunohistochemical study of 25 PCNSLs for LC3B, p62, and M6PR, comparing it with clinicopathological characteristics. Fourteen (56%) and eleven (44%) PCNSLs were of low and high LC3B expression, respectively. p62 expression was present in most tumors (n = 21, 84%). M6PR was present in all tumors, with 14 (56%) and 11 (44%) cases being of low and high M6PR expression, respectively. LC3B expression was correlated with the performance status (PS) (p = 0.04). No association was found with other clinical parameters, such as deep structure invasion, multiple lesions, complete response, and recurrence after response. p62 showed a strong positive association with MUM1 expression (p = 0.0005). M6PR expression showed a positive correlation (p = 0.04) with PD-L1 expression. No association was found with p53, Ki67, CD8, BCL2, BCL6, or double MYC/BLC2 co-expressors. No association of LC3B, p62, and M6PR expression with survival was found. Our findings provide evidence for the possible presence of autophagic markers in PCNSLs and, thus, for possible treatment targets.
format article
author Georgia Karpathiou
Silvia-Maria Babiuc
Florian Camy
Elise Ferrand
Alexandra Papoudou-Bai
Jean Marc Dumollard
Jerome Cornillon
Michel Peoc’h
author_facet Georgia Karpathiou
Silvia-Maria Babiuc
Florian Camy
Elise Ferrand
Alexandra Papoudou-Bai
Jean Marc Dumollard
Jerome Cornillon
Michel Peoc’h
author_sort Georgia Karpathiou
title Primary central nervous system lymphomas express immunohistochemical factors of autophagy
title_short Primary central nervous system lymphomas express immunohistochemical factors of autophagy
title_full Primary central nervous system lymphomas express immunohistochemical factors of autophagy
title_fullStr Primary central nervous system lymphomas express immunohistochemical factors of autophagy
title_full_unstemmed Primary central nervous system lymphomas express immunohistochemical factors of autophagy
title_sort primary central nervous system lymphomas express immunohistochemical factors of autophagy
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/837f0784766340ea88d282e1ac2346c4
work_keys_str_mv AT georgiakarpathiou primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy
AT silviamariababiuc primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy
AT floriancamy primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy
AT eliseferrand primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy
AT alexandrapapoudoubai primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy
AT jeanmarcdumollard primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy
AT jeromecornillon primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy
AT michelpeoch primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy
_version_ 1718419017415262208